周猛冲;李春明;李海龙;杨宇飞;

• 1:河南远大生物制药有限公司研发部

摘要(Abstract)：

狂犬病是由狂犬病病毒引起的一种人和动物共患的急性传染病,对人类的身体健康造成了巨大的威胁。当前人类预防狂犬病的最有效措施是注射具有较强免疫原性的狂犬病疫苗。本文主要对狂犬病疫苗在近年来的研究进展作一综述。

关键词(KeyWords)： 狂犬病;疫苗

Abstract:

Keywords:

基金项目(Foundation):

作者(Authors): 周猛冲;李春明;李海龙;杨宇飞;

DOI: 10.13200/j.cnki.cjb.002455

参考文献(References)：

• [1]RIBADEAU-DUMAS F,DACHEUX L,BOURHY H.Rabies[J].Med Sci(Paris),2013,29(1):47-55.
• [2]WHO.WHO Expert Consultation on Rabies.Second report[J].World Health Organ Tech Rep Ser,2013(982):1-139.
• [3]Food and Agriculture Organization of United Nations.FAO,OIE and WHO Unite to Eliminate Human Rabies and Control the Disease in Animals[N/OL].(2013-09-28).[2013-09-28].http://www.fao.org/news/story/en/item/198087/icode/.
• [4]MENG F D,WU D,SUI C G.Human rabies incidence in China:trends and predictions from a time series analysis from 2004trough 2015[J].Chin J Health Stat,2016,33(3):389-391,395.(in Chinese)孟凡东,吴迪,隋承光.2004-2015年中国狂犬病发病数据ARIMA乘积季节模型的建立及预测[J].中国卫生统计,2016,33(3):389-391,395.
• [5]ROUROU S,BEN AYED Y,TRABELSI K,et al.An animal component free medium that promotes the growth of various animal cell lines for the production of viral vaccines[J].Vaccine,2014,32(24):2767-2769.
• [6]LU Y K,TANG X P,LU J H,et al.The relationship between abnormal reaction and sero-antibody response to the rabies vaccine[J].Prog in Microbiol Immun,1997,25(1):36-39.(in Chinese)陆裕宽,唐小萍,陆家华,等.浓缩狂犬病疫苗接种不良反应与血清抗体水平分析[J].微生物学和免疫学进展,1997,25(1):36-39.
• [7]河南普新生物工程有限公司.应用科技类成果[EB/OL].(2003-01-01)[2018-02-06].http://dbpub.cnki.net/grid2008/dbpub/detail.aspx?dbcode=SNAD&dbname=SNAD&filename=SNAD000000177646mfk mf.
• [8]CHEN R F,HUANG L S,ZHENG J B,et al.Emergency treatment on facial laceration of dog bite wounds with imme-diate primary closure:a prospective randomized trial study[J].BMCEmerg Med,2013,13(Suppl 1):S2.
• [9]WANG Z,CHEN Y H,DENG F F,et al.Comparison of two diagnostic kits for Ig G-antibody to rabies virus[J].Prog in Microbiol Immun,2018,46(1):39-42.(in Chinese)王真,陈燕花,邓芳芳,等.两种狂犬病毒Ig G抗体检测试剂盒的比较[J].微生物学和免疫学杂志,2018,46(1):39-42.
• [10]XU J,ZHOU R.Study the safety and the adverse reaction of domestic human diploid cell rabies vaccine(HDCV)in children and the old[J].J Med Pest Control,2016,32(11):1234-1237.(in Chinese)许婧,周蓉.国产人二倍体细胞狂犬病疫苗用于儿童和老人的安全性观察分析[J].医学动物防制,2016,32(11):1234-1237.
• [11]WU X F,SMITH T D,RUPPRECHT C E.From brain passage to cell adaptation:the road of human rabies vaccine development[J].Expert Rev Vaccines,2011,10(11):1597-1608.
• [12]WHO.Rabies vaccines[J].Wkly Epidemiol Rec,2002,77(14):109-119.
• [13]CAI Y,ZHOU R,LI S Y,et al.Safety and immunogenicity of domestic freeze-dried rabies vaccine(human diploid cells)for human use[J].Chin J Biologicals,2015,28(5):510-513,517.(in Chinese)蔡勇,周蓉,李声友,等.国产冻干人用狂犬病疫苗(人二倍体细胞)的安全性及免疫原性观察[J].中国生物制品学杂志,2015,28(5):510-513,517.
• [14]PERRIN P,THIBODEAU L,SUREAU P.Rabies immunosome(subunit vaccine)structure and immunogenicity.Pre-and postexposure protection studies[J].Vaccine,1985,3(3):325-332.
• [15]YELVERTON E,NORTON S,OBIJESKI J F,et al.Rabies virus glycoprotein analogs:biosynthesis in Escherichia coli[J].Science,1983,219(4585):614-620.
• [16]LATHE R F,KIENY M P,SCHMITT D,et al.M13 bacteriophage vectors for the expression of foreign proteins in Escherichia coli:the rabies glycoprotein[J].J Mol Appl Genet,1984,2(4):331-342.
• [17]KLEPFER S R,DEBOUCK C,UFFELMAN J,et al.Characterization of rabies glycoprotein expressed in yeast[J].Arch Virol,1993,128(3-4):269-286.
• [18]SAKAMOTO S,IDE T,TOKIYOSHI S,et al.Studies on the structures and antigenic properties of rabies virus glycoprotein analogues produced in yeast cells[J].Vaccine,1999,17(3):205-218.
• [19]LOZA-RUBIO E,ROJAS E,G仵MEZ L,et al.Development of an edible rabies vaccine in maize using the Vnukovo strain[J].Dev Biol(Basel),2008,131:477-482.
• [20]LI Y Y,DAI B X,TAN L X,et al.New progress and prospects of rabies vaccine[J].Biotechnol Business,2017,1(1):100-104.(in Chinese)李岩异,戴碧璇,谭丽霞,等.狂犬疫苗的研究进展[J].生物产业技术,2017,1(1):100-104.
• [21]XIANG Z Q,SPITALNIKE S L,TRAN M,et al.Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus[J].Virology,1994,199(1):132-140.
• [22]CENNA J,HUTER M,TAN G S,et al.Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates[J].J Infect Dis,2009,200(8):1251-1260.
• [23]ASTRAY R M,JORGE S A,PEREIRA C A.Rabies vaccine development by expression of recombinant viral glycoprotein[J].Arch Virol,2017,162(2):323-332.
• [24]CHOUDHRY A,MATHENA J,ALBANO J D,et al.Safety evaluation of adenovirus type 4 and type 7 vaccine live,oral in military recruits[J].Vaccine,2016,34(38):4558-4564.
• [25]WEYER J,RUPPRECHT C E,MANS J,et al.Generation andevaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies[J].Vaccine,2007,25(21):4213-4222.
• [26]CHEN Z H,ZHOU M,GAO X D.A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein[J].J Virol,2013,87(6):2986-2993.
• [27]靳红亮.狂犬病病毒磷蛋白重组人5型腺病毒的构建及生物学特性的初步研究[D].吉林长春:吉林农业大学,2015:9-13.
• [28]刘林立,陈中秋,卫广森.兽用狂犬病疫苗研究进展[C].第八届全国会员代表大会暨第十五次学术研讨会论文集.江苏徐州,2013:139-141.
• [29]ZHOU H,LI Y,CHEN R F,et al.Technical guideline for human rabies prevention and control(2016)[J].Chin J Epi-demiol,2016,37(2):139-163.(in Chinese)周航,李昱,陈瑞丰,等.狂犬病预防控制技术指南(2016)[J].中华流行病学杂志,2016,37(2):139-163.
• [30]郝晓芳,张加勇,徐佳,等.重组病毒载体疫苗的研究进展[J].黑龙江畜牧兽医,2016,69(7上):68-71.
• [31]江馗语.狂犬病疫苗研究进展[J].中国工作犬业,2015,(11):15-17.
• [32]HAN N J.Construction and immunogenicity of rabies virus glucoprotein recombinant pseudorabies virus mediated by transposon[D].Changchun:Jilin University,2010:43-70.(in Chinese)韩乃君.转座子介导的伪狂犬病毒重组狂犬病疫苗构建与免疫研究[D].吉林长春:吉林大学,2012:43-70.
• [33]HUANG Y,CHEN Z H,HUANG J H.Parainfluenza virus 5expressing the G protein of rabies virus protects mice after rabies virus infection[J].J Virol,2015,89(6):3427-3429.
• [34]FABER M,LI J,KEAN R B,et al.Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus[J].Proc Natl Acad Sci USA,2009,106(27):11300-11305.
• [35]XIE T B,MING P G,TANG F,et al.Reconstruction and rescue of reverse genetic system of rabies virus CTN strain[J].Chin J Biologicals,2015,28(11):1121-1126.(in Chinese)解庭波,明平刚,唐芳,等.狂犬病病毒CTN株反向遗传系统的改造及拯救[J].中国生物制品学杂志,2015,28(11):1121-1126.
• [36]ZHU Y L,SUN P L,YU X J,et al.Advances in the study of rabies vaccine adjuvants[J].J Pathog Biol,2017,12(3):278-282.(in Chinese)朱业蕾,孙培录,于学杰,等.狂犬病疫苗佐剂的研究进展[J].中国病原生物学杂志,2017,12(3):278-282.
• [37]ZHANG Y,ZHANG S F,LI W,et al.A novel rabies vaccine based-on toll-like receptor 3(TLR3)agonist PIKA adjuvant exhibiting excellent safety and efficacy in animal studies[J].Virology,2016,489(2):165-172.
• [38]张译.国家重大新药项目"皮卡狂犬病疫苗"开启国际多中心三期临床试验[N].依生生物企业新闻,2017-10-12.
• [39]李颖.皮卡佐剂疫苗获技术突破[N].科技日报,2016-01-21(6).
• [40]Chinese Pharmacopoeia Commission.Pharmacopoeia of People's Repubic of China(VolⅢ)[S].Beijing:China Med Sci Press,2015:31.(in Chinese)国家药典委员会.中华人民共和国药典(三部)[S].北京:中国医药科技出版社,2015:31.